Agape Capital Expenditures from 2010 to 2026
| ATPC Stock | 2.26 0.18 8.65% |
Capital Expenditures | First Reported 2016-09-30 | Previous Quarter 11 | Current Value 7 | Quarterly Volatility 14.6 K |
Check Agape ATP financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Agape ATP's main balance sheet or income statement drivers, such as Depreciation And Amortization of 234.2 K, Selling General Administrative of 3.8 M or Other Operating Expenses of 2.4 M, as well as many indicators such as Price To Sales Ratio of 3.1 K, Dividend Yield of 0.0 or PTB Ratio of 1.8 K. Agape financial statements analysis is a perfect complement when working with Agape ATP Valuation or Volatility modules.
Agape | Capital Expenditures | Build AI portfolio with Agape Stock |
Analyzing Agape ATP's Capital Expenditures over time reveals critical patterns in financial health and operational efficiency. This metric helps investors evaluate trends, identify inflection points, and make informed decisions based on historical performance. Understanding how Capital Expenditures has evolved provides context for assessing Agape ATP's current valuation and future prospects.
Latest Agape ATP's Capital Expenditures Growth Pattern
Below is the plot of the Capital Expenditures of Agape ATP over the last few years. Capital Expenditures are funds used by Agape ATP to acquire physical assets such as property, industrial buildings or equipment. This type of outlay is used by management to increase the scope of Agape ATP operations. These expenditures can include everything from repairing an office equipment, building a brand new facility, or writing new software. It is Agape ATP's Capital Expenditures historical data analysis aims to capture in quantitative terms the overall pattern of either growth or decline in Agape ATP's overall financial position and show how it may be relating to other accounts over time.
| Capital Expenditures | 10 Years Trend |
|
Capital Expenditures |
| Timeline |
Agape Capital Expenditures Regression Statistics
| Arithmetic Mean | 15,674 | |
| Geometric Mean | 0.00 | |
| Coefficient Of Variation | 152.71 | |
| Mean Deviation | 20,528 | |
| Median | 0.00 | |
| Standard Deviation | 23,937 | |
| Sample Variance | 573M | |
| Range | 60.6K | |
| R-Value | 0.83 | |
| Mean Square Error | 189.8M | |
| R-Squared | 0.69 | |
| Significance | 0.000037 | |
| Slope | 3,936 | |
| Total Sum of Squares | 9.2B |
Agape Capital Expenditures History
About Agape ATP Financial Statements
Agape ATP stakeholders use historical fundamental indicators, such as Agape ATP's Capital Expenditures, to determine how well the company is positioned to perform in the future. Although Agape ATP investors may analyze each financial statement separately, they are all interrelated. For example, changes in Agape ATP's assets and liabilities are reflected in the revenues and expenses on Agape ATP's income statement, which ultimately affect the company's gains or losses. Understanding these patterns can help in making the right long-term investment decisions in Agape ATP. Please read more on our technical analysis and fundamental analysis pages.
| Last Reported | Projected for Next Year | ||
| Capital Expenditures | 57.7 K | 60.6 K |
Also Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.When determining whether Agape ATP offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of Agape ATP's financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Agape Atp Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Agape Atp Stock:Check out the analysis of Agape ATP Correlation against competitors. For information on how to trade Agape Stock refer to our How to Trade Agape Stock guide.You can also try the ETFs module to find actively traded Exchange Traded Funds (ETF) from around the world.
Will Health Care Providers & Services sector continue expanding? Could Agape diversify its offerings? Factors like these will boost the valuation of Agape ATP. If investors know Agape will grow in the future, the company's valuation will be higher. Accurate valuation requires analyzing both current fundamentals and future growth trajectories. Every Agape ATP data point contributes insight, yet successful analysis hinges on identifying the most consequential variables.
Earnings Share (12.50) | Revenue Per Share | Quarterly Revenue Growth 0.119 | Return On Assets | Return On Equity |
The market value of Agape ATP is measured differently than its book value, which is the value of Agape that is recorded on the company's balance sheet. Investors also form their own opinion of Agape ATP's value that differs from its market value or its book value, called intrinsic value, which is Agape ATP's true underlying value. Seasoned market participants apply comprehensive analytical frameworks to derive fundamental worth and identify mispriced opportunities. Because Agape ATP's market value can be influenced by many factors that don't directly affect Agape ATP's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Understanding that Agape ATP's value differs from its trading price is crucial, as each reflects different aspects of the company. Evaluating whether Agape ATP represents a sound investment requires analyzing earnings trends, revenue growth, technical signals, industry dynamics, and expert forecasts. Meanwhile, Agape ATP's quoted price indicates the marketplace figure where supply meets demand through bilateral consent.